Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Original Research

Accepted on 30 Jun 2025

The unexploited potential of data systems tracking medicines utilization: An opportunity to improve access to oncology combination therapies

in Drugs Outcomes Research and Policies

Steven Simoens
David Dodwell
Michael Hartevelt
Peter Lindgren
Michele Pistollato
Lisa§ G Pont
Caridad Pontes
Alexander Roediger
Antun Sablek
Eric Van Ganse

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1532022

Systematic Review

Accepted on 27 Jun 2025

Effectiveness and Safety of Direct Oral Anticoagulants Versus Vitamin K Antagonists in Atrial Fibrillation Patients with Liver Disease: A Systematic Review and Meta-analysis

in Drugs Outcomes Research and Policies

Qiang Zhou
Xiang Liu
Shuyu Liu
Zhi-Chun Gu
Yanzi Wu
Yuansu Yang
Yingying Tao
Meng Wei

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1620394

123 views

Review

Accepted on 27 Jun 2025

Pharmacodynamics, pharmacokinetics, interactions with other drugs, toxicity and clinical effectiveness of proton pump inhibitors

in Drugs Outcomes Research and Policies

Łukasz Wołowiec
Joanna Osiak
Albert Jaśniak
Michał Janiak
Lidia Wydeheft
Magdalena Łukasiak
Małgorzata Pellowska
Grzegorz Grześk

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1507812

Review

Accepted on 26 Jun 2025

A scoping review about smoking, smoking cessation and their effects on anti-tuberculosis agents: insights into drug metabolisms, safety, and effectiveness

in Drugs Outcomes Research and Policies

Carlo Maria Bellanca
Simone Pietro Polosa
Egle Augello
Giulia Di Benedetto
Chiara Burgaletto
Anna Flavia Cantone
Gabriella Gaudio
Giuseppe Nunnari
Davide Campagna
Jennifer M Nailes

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1606150

119 views

Original Research

Accepted on 26 Jun 2025

The effect of remimazolam and propofol on post-hysteroscopy sleep quality under general anesthesia: a post-hoc analysis

in Drugs Outcomes Research and Policies

Chen Yang
Le Zhang
Yan Cheng
jianying hu
yuyan Nie
Shen Sun
Shaoqiang Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1618190

Original Research

Published on 26 Jun 2025

The relationships between social support, medication adherence, and glycemic control among inpatients with type 2 diabetes: a cross-sectional survey in Xi’an, China

in Drugs Outcomes Research and Policies

Haiyan Li
Hui Min
Lu Zhang
Youjia Li
Jing Wang
Xiaoni Jia

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1634768

227 views

Policy Brief

Accepted on 25 Jun 2025

Trends in Good Laboratory Practice studies submitted for the marketing authorization of pharmaceuticals in Japan

in Drugs Outcomes Research and Policies

Yusuke Oku
Hitoshi Someya

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1591433

147 views

Original Research

Accepted on 25 Jun 2025

Efficacy and Safety of Telitacicept in Systemic Lupus Erythematosus with Lupus Nephritis and Nephrotic Syndrome: A 12-Month Retrospective Cohort Study

in Drugs Outcomes Research and Policies

Liujun Li
Minying Liu
Qiang Xu
Changsong Lin
Qing-Ping Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1613790

142 views

Original Research

Published on 25 Jun 2025

Association of morphine vs. fentanyl prescription dispensation with adverse clinical outcomes

in Drugs Outcomes Research and Policies

Carlen Reyes
Maria Antonia Pou
Cesar Diaz-Torne
Cristina Carbonell-Abella
Carlos Brotons
Daniel Martinez-Laguna

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1579634

290 views

Review

Published on 25 Jun 2025

Clinical and economic consequences of medication nonadherence: a review of systematic reviews

in Drugs Outcomes Research and Policies

Maria Achterbosch
Nilay Aksoy
George D. Obeng
David Ameyaw
Tamás Ágh
Job F. M. van Boven

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1570359

529 views

Original Research

Accepted on 24 Jun 2025

Contextual factors in Value-based Decision Support to enhance health technologies adoption: The case of biosimilars

in Drugs Outcomes Research and Policies

Maximilian Otte
Zoltán Kaló
Hussain Al-Omar
Meindert Boysen
Yingyao Chen
Ana Paula Beck Da Silva Etges, Ph.D, Eng.
Guvenc Kockaya
Iñaki Gutiérrez-Ibarluzea
AHMED MOHAMMED SEYAM
Deirdre Mullen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1599013

132 views

Opinion

Accepted on 24 Jun 2025

Reducing Carbon, Enhancing Care: The Future of Sustainable Medicine

in Drugs Outcomes Research and Policies

Alessio Provenzani
Mia Como
Gennaro Martucci

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1637531

250 views

Original Research

Accepted on 24 Jun 2025

Cost-effectiveness analysis of sintilimab additional to chemoradiotherapy in highrisk locoregionally advanced nasopharyngeal carcinoma

in Drugs Outcomes Research and Policies

Longjiang She
Siqi Tang
Jiaqi Han
Guichao Liu
Lusi Chen
Yang Zhang
Weijun Luo
Weihan Zuo
Feng Ma
Yan Xiong

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1548710

Systematic Review

Published on 24 Jun 2025

Indirect comparison of the efficacy and safety of alirocumab and evolocumab on major cardiovascular events: a systematic review and network meta-analysis

in Drugs Outcomes Research and Policies

Leyu Xu
Ming Lei
Liren Li
Yilei Li
Chunping Gu
Ping Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1555508

448 views

Original Research

Accepted on 23 Jun 2025

Sedative Exposure and Mortality in Intracranial Hypertensive Tuberculous Meningitis: A Cohort Study with Propensity-Score Matching and Machine Learning Analysis

in Drugs Outcomes Research and Policies

Shijuan Cui
Fazheng Shen
Jianing Liang
Fan Li
Xiangyang Wang
Xin Liu
Haigang Chang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1620858

105 views

Systematic Review

Accepted on 23 Jun 2025

Low-dose trimethoprim-sulfamethoxazole for prophylaxis of pneumocystis jirovecii pneumonia in HIV-uninfected patients: a systematic review and meta-analysis

in Drugs Outcomes Research and Policies

Hui-Bin Huang
Jia-Heng Shi
Yan-Ge Hu
Yibing Zhu
Da-Xing Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1545436

102 views